These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 33960703

  • 21. Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations.
    Chevrier S, Arnould L, Ghiringhelli F, Coudert B, Fumoleau P, Boidot R.
    Int J Oncol; 2014 Sep; 45(3):1167-74. PubMed ID: 24990411
    [Abstract] [Full Text] [Related]

  • 22. Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing.
    Zhou X, Xu X, Tian Z, Xu WY, Cui Y.
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2277-2287. PubMed ID: 32572558
    [Abstract] [Full Text] [Related]

  • 23. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL, Montgomery ND, Patel NM, Civalier CJ, Dodd LG, Gulley ML, Booker JK, Weck KE.
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [Abstract] [Full Text] [Related]

  • 24. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
    Preusser M, Berghoff AS, Koller R, Zielinski CC, Hainfellner JA, Liebmann-Reindl S, Popitsch N, Geier CB, Streubel B, Birner P.
    Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
    [Abstract] [Full Text] [Related]

  • 25. Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma.
    Sato S, Nagahashi M, Koike T, Ichikawa H, Shimada Y, Watanabe S, Kikuchi T, Takada K, Nakanishi R, Oki E, Okamoto T, Akazawa K, Lyle S, Ling Y, Takabe K, Okuda S, Wakai T, Tsuchida M.
    Sci Rep; 2018 Jan 17; 8(1):1005. PubMed ID: 29343775
    [Abstract] [Full Text] [Related]

  • 26. Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma.
    Kim EY, Cho EN, Park HS, Hong JY, Lim S, Youn JP, Hwang SY, Chang YS.
    Cancer Biol Ther; 2016 Jan 17; 17(3):237-45. PubMed ID: 26785607
    [Abstract] [Full Text] [Related]

  • 27. Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma.
    Kulda V, Polivka J, Svaton M, Vanecek T, Buresova M, Houfkova K, Bagheri MS, Knizkova T, Vankova B, Windrichova J, Macan P, Babuska V, Pesta M.
    Cancer Genomics Proteomics; 2023 Jan 17; 20(4):404-411. PubMed ID: 37400146
    [Abstract] [Full Text] [Related]

  • 28. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.
    Descarpentries C, Leprêtre F, Escande F, Kherrouche Z, Figeac M, Sebda S, Baldacci S, Grégoire V, Jamme P, Copin MC, Tulasne D, Cortot AB.
    J Thorac Oncol; 2018 Dec 17; 13(12):1873-1883. PubMed ID: 30195702
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
    Bonanno L, Pavan A, Ferro A, Calvetti L, Frega S, Pasello G, Aprile G, Guarneri V, Conte P, Rete Oncologica Veneta (ROV).
    Oncologist; 2020 Dec 17; 25(12):e1996-e2005. PubMed ID: 32557976
    [Abstract] [Full Text] [Related]

  • 37. Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.
    Pruis MA, Geurts-Giele WRR, von der TJH, Meijssen IC, Dinjens WNM, Aerts JGJV, Dingemans AMC, Lolkema MP, Paats MS, Dubbink HJ.
    Lung Cancer; 2020 Feb 17; 140():46-54. PubMed ID: 31862577
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.